Home / Compliance actions / 681586

FDA Warning Letter — Evolutionary Biologics Inc

Case 681586 — FEI 3030708917

The FDA took a Warning Letter action against Evolutionary Biologics Inc on Dec 31, 2024 (New York, NY). The action was issued by CBER and concerns biologics products.

Action Details

Facility
Evolutionary Biologics Inc
Date
Dec 31, 2024
Fiscal Year
2025
Product Type
Biologics
Center
CBER
Location
New York, NY (United States)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.